Emily J Tracey, PA | |
57 Beam Ln Ste 202, Fishersville, VA 22939-2350 | |
(540) 932-0980 | |
(540) 932-0979 |
Full Name | Emily J Tracey |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 57 Beam Ln Ste 202, Fishersville, Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881905263 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Emily J Tracey, PA Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Emily J Tracey, PA 57 Beam Ln Ste 202, Fishersville, VA 22939-2350 Ph: (540) 932-0980 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.
InterMune, Inc. today announced results of all three cohorts from a 15-day Phase 1b multiple-ascending-dose (MAD) study of low doses of danoprevir (also known as RG7227 and ITMN-191) boosted by low-dose ritonavir (RTV) in patients chronically infected with hepatitis C virus (HCV) genotype-1.
According to the West Australian branch of the Australian Medical Association (AMA) doctors should not be overworked while attempting to meet the four hour rule.
Patients with advanced cancer are to test a therapy aimed at reducing their symptoms and improving quality of life.
IMRIS Inc. ("IMRIS" or the "Company") and Brigham and Women's Hospital, ("BWH") today announced a comprehensive agreement in support of BWH's vision of bringing the most advanced multi-modality image guided therapy suite in the world to its facility in Boston, Massachusetts.
› Verified 3 days ago